Urinary Incontinence, Stress Clinical Trial
— HER-PhysioOfficial title:
Physiotherapy for Stress Urinary Incontinence: Feasibility Study for a Randomized Controlled Trial of Hip External Rotation Exercise Training Versus Pelvic Floor Muscle Exercise Training
Verified date | May 2022 |
Source | University of Alberta |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This RCT is a feasibility study to evaluate the Lois Hole Hospital for Women's Urogynecology Clinic's ability to recruit and randomize SUI patients to the proposed RCT, and to test the study procedures and follow-up schedule for participants. The study interventions used in the feasibility study will be training of (1) Hip Extension Rotation (HER) exercises alone, (2) HER exercises in combination with Pelvic Floor Muscle (PFM) exercises, or (3) PFM exercises alone (control/usual care) in the treatment of SUI.
Status | Completed |
Enrollment | 31 |
Est. completion date | July 10, 2019 |
Est. primary completion date | July 10, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Stress urinary incontinence - Attending Lois Hole Hospital for Women Urogynecology Clinic - Referred for physiotherapy for stress urinary incontinence - Able to toilet independently - Able to undertake hip rotation exercises - Able to speak and read English Exclusion Criteria: - Urge urinary incontinence - Using a pessary - Neurological or cognitive impairment - Using other treatment for incontinence - Unable to complete study forms - Unable to understand educational instruction |
Country | Name | City | State |
---|---|---|---|
Canada | Lois Hole Hospital for Women, Royal Alexandra Hospital | Edmonton | Alberta |
Lead Sponsor | Collaborator |
---|---|
University of Alberta | Physiotherapy Alberta - College + Association |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility: achieve recruitment of 30 women over 12 months | Is recruitment feasible? "Feasibility" is defined as achieving recruitment target of 30 recruits within 12 months | 12 months | |
Primary | Feasibility: achieve follow-up for 60% of recruits over 12 months | Is follow-up complete for 60% of recruits? | 12 months | |
Secondary | Pelvic floor muscle strength | Strength will be measured using Peritron perineometer | 12 & 24 weeks | |
Secondary | External hip rotator muscle strength | Strength will be measured using Microfit ET3 | 12 & 24 weeks | |
Secondary | Diary-reported urinary incontinence | 3-day bladder diary to record amount and reason for leakage | 12 & 24 weeks | |
Secondary | Incontinence-related quality of life (distress) | UDI-6 questionnaire (measure of distress caused by incontinence, 0 minimum to 100 maximum) | 12 & 24 weeks | |
Secondary | Incontinence-related quality of life (impact) | IIQ-7 questionnaire (measure of impact of incontinence, 0 minimum to 100 maximum) | 12 & 24 weeks | |
Secondary | Patient mobility (walking) | Six minute walk test - distance walked (metres) | 12 & 24 weeks | |
Secondary | Patient mobility | "timed up and go" test - time in sconds | 12 & 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02001714 -
Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms
|
N/A | |
Not yet recruiting |
NCT00523068 -
Pharmacological vs Surgical Treatment for Mixed Incontinence
|
Phase 4 | |
Completed |
NCT00904969 -
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
|
N/A | |
Completed |
NCT00190814 -
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
|
Phase 3 | |
Completed |
NCT00190827 -
Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)
|
Phase 3 | |
Terminated |
NCT00247286 -
Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.
|
Phase 4 | |
Completed |
NCT01959347 -
Combined Treatment for Mixed Incontinence
|
Phase 3 | |
Completed |
NCT00244296 -
To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms
|
Phase 4 | |
Not yet recruiting |
NCT05570071 -
A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI.
|
N/A | |
Completed |
NCT02334878 -
Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence
|
Phase 3 | |
Completed |
NCT01382602 -
Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study
|
Phase 3 | |
Recruiting |
NCT02750878 -
Surgical Consent Process for Trans-obturator Tape Slings.
|
N/A | |
Completed |
NCT02296099 -
Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence
|
Phase 4 | |
Completed |
NCT02599051 -
Transobturator Verus Single Incision Slings
|
N/A | |
Completed |
NCT00138749 -
An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.
|
Phase 2 | |
Terminated |
NCT03614611 -
Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence
|
N/A | |
Completed |
NCT03722719 -
The Knack on Female Stress Urinary Incontinence
|
N/A | |
Active, not recruiting |
NCT02275728 -
Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence
|
N/A | |
Terminated |
NCT01358214 -
Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape)
|
N/A | |
Active, not recruiting |
NCT01323426 -
Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter.
|
Phase 1/Phase 2 |